Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease.
Saved in:
| Title: | Dose-Response Analysis of the Effect of Carbidopa-Levodopa Extended-Release Capsules (IPX066) in Levodopa-Naive Patients With Parkinson Disease. |
|---|---|
| Authors: | Mao ZL; Impax Specialty Pharma, a division of Impax Laboratories, Inc, Hayward, CA, USA., Modi NB; Impax Specialty Pharma, a division of Impax Laboratories, Inc, Hayward, CA, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2016 Aug; Vol. 56 (8), pp. 974-82. Date of Electronic Publication: 2016 Jan 18. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
